28Aug 2018

ASSOCIATION BETWEEN PLASMA VITAMIN D LEVEL AND METASTASIS IN BREAST CANCER.

  • Biomedical Departement of Medical Faculty of Universitas Sumatera Utara.
  • Oncology Departement of Adam Malik Hospital Medan.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Metastasis is the leading cause of death in breast cancer. Experimental study found anti-invasive and anti-metastatic effects of vitamin D in cancer cells, but epidemiological studies supporting the anti-invasive and anti-metastatic effects of vitamin D are still inconsistent. The aim of the study was to investigate the association of plasma vitamin D levels and metastasis in breast cancer patients. Methods: A descriptive observational cross sectional study was performed on 50 newly diagnosed breast cancer patients at Adam Malik Hospital Medan. Plasma vitamin D levels were measured using enzyme-linked immunosorbent assay method. Chest x-ray, liver ultrasonography and fine-needle biopsy were performed to find cancer cell rmetastasis. The relationship between plasma vitamin D levels and metastases was analyzed by unpaired t-test. RESULTS: The mean plasma vitamin D levels in patients with positive distant metastatis and in patients with negative distant metastases were 26.900 ? 10.165 ng / ml and 27.561 ? 8.467 ng / ml. There were no association between plasma level vitamin D and metastasis in this study.

  1. Ajibade AA, Kirk JS, Karasik E, Gillard B, Mosser MT, et al. Early Growth Inhibition is followed by increased metastatic disease with vitamin D ( calcitriol ) treatment in the TRAMP model of prostate cancer. Plos One 2014; 9(2)
  2. Apoloslou P, Fostira F. Hereditary breast cancer : The era of new susceptibility genes. Biomed Research International 2013
  3. Anisiewicz A, Pawlik A, Filip-Psurska, Turlej E, Dzimira S, Milczarek M et al. Unvaforable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer. International Journal of Oncology 2018; 52:103 - 126
  4. Bodicoat DH,Schoemaker MJ, Jones ME, McFadden E, Griffin J, Asworth A, J. Timing of pubertal stages and breast cancer risk : The breakthrough generations study. 2014. Breast Cancer Research; 16:R18
  5. Chang K, Chen S, Yeh C, Pang J, Shen S, Hsu J, et al. Mart-10, a less calcemik vitamin D analog , is more potent than 1α,25-dihydroxyvitamin D3 inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro. The Journal of Steroid Biochemistry and Molecular Biology 2014; 139: 54-60
  6. Donepudi M, Kondapalli K, Apos J, Venkanteshan P. Breast cancer statistics and markers. Journal of cancer research and Therapeutics 2014; 10(3)
  7. Elzehery RR, Baiomy AA, Hegazy MA, Fares R, El-Gilani A, Hegazi R. Vitamin D status, receptor gene Bsm1(A/G) polymorphism and breast cancer in group of Egyptian females. The Egyptian Journal of Medical Human Genetics 2016,
  8. Jeon S, Shin E. 2018. Exploring vitamin D metabolism and function in cancer. Experimental and Molecular Medicine; 50:20
  9. Kim HJ, Lee YM, Ko BS, Lee JW, Yu JH, Son BH et al. Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer. Ann Surg Oncol 2011; 18 : 1830-1836
  10. Krishnan AV, Swami S, Feldman D. Vitamin D and breast cancer : Inhibition of estrogen synthesis and signaling. Journal of Steroid and Molecular Biology 2010; 121: 343-348
  11. Lambert AW, Pattabiraman DR, Weinberg RA. Emerging Biological Principles of Metastasis. Cell 2017; 168
  12. Sofi NY, Jain M, Seenu V, Kamal VK, Pandey R. Nutritional risk factor and status of serum 25(OH)D levels in patient with breast cancer : a case control study in India. The Journal of Steroid and Biochemistry and Molecular Biologi 2018; 175: 55-59
  13. Tazzite A, Jouhadi H, Saiss K, Benider A, Nadifi S, Relationship between family history of breast cancer and clinicopathological features in Moroccan patients. Ethiop J Health Sci. 2013; 23(2)
  14. Thanasittichai S, Chaiwerawattana A, Prasitthipayong A. Association Of Vitamin D level with clinicopathological Features in breast cancer. Asian Pacific Journal of Cancer Prevention 2015; 16
  15. Wang Y, Zhu J, DeLuca HF. Where is vitamin D receptor ? Archives of Biochemistry and Biophysics 2012; 532: 123-133
  16. Yao S, Kwan ML, Ergas IJ, Roh JM, Cheng TD, Hong C. Higher serum level of vitamin D at diagnosis are associated with better survival in prospective cohort of 1666 women with breast cancer : A case-cohort analysis in pathways study. JAMA Oncol 2017; 3(3): 351-357
  17. Williams JD, Aggarwal A, Swami S, Krishnan AV, Ji L, Albertelli MA, Feldman BJ. Tumor autonomous effects of vitamin D defisciency promote breast cancer metastasis. Endocrinology 2016;157(4): 1341-1347
  18. Wu Y, Sarkissyan M, Clayton S, Chlebowski R, Vadgama J. Association of vitamin D3 level with breast cancer risk and prognosis in African-American and Hispanic Women. Cancers 2017;9:144
  19. Wu X, Zhou T, Cao N, Ni J, Wang X. Role of vitamin D metabolism and activity on carcinogenesis. Oncology Research 2015; 22: 129-137
  20. Zhalehjoo N, Shakiba Y, Panjehpour M. Gene expression profiles of CYP24A1 and CYP27B1 in malignant and normal breast tissue. Molecular Medicine Reports 2017; 15: 467-473
  21. Zhang X, Harbeck N, Jeschke U, Doisneau-Sixou S. Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer. J Cancer Res Clin Oncol 2017;143:1107-1122.

[Ira Astuti Hasibuan, Sry Suryani Widjaja and Denny Rifsal Siregar. (2018); ASSOCIATION BETWEEN PLASMA VITAMIN D LEVEL AND METASTASIS IN BREAST CANCER. Int. J. of Adv. Res. 6 (Aug). 1017-1021] (ISSN 2320-5407). www.journalijar.com

Ira Astuti hasibuan
Biomedical Departement of Medical Faculty, Universitas Sumatera Utara

DOI:

Article DOI: 10.21474/IJAR01/7606      
DOI URL: https://dx.doi.org/10.21474/IJAR01/7606

Download Full Paper

Download PDF No. of Downloads: 9 | No. of Views: 36